Audit MicroControls Linearity LQ Cystatin-C
FDA 510(k) K143571 · Aalto Scientific, Ltd.
510(k) numberK143571
Submission
- Device name
- Audit MicroControls Linearity LQ Cystatin-C
- Applicant
- Aalto Scientific, Ltd.
Carlsbad, CA, US - Received
- December 17, 2014
- Decision date
- January 23, 2015
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- JJX – Single (Specified) Analyte Controls (Assayed And Unassayed)
- Device class
- Class I (low risk)
- Regulation
- 21 CFR 862.1660
- Specialty
- Clinical Chemistry
Other 510(k)s with product code JJX
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K170678 | Beta-CrossLaps CalCheck 5JJX · Traditional | Roche Diagnostics | 04/04/2017SE |
| K162173 | Elecsys CYFRA 21-1 CalCheck 5JJX · Traditional | Roche Diagnostics | 01/12/2017SE |
| K162514 | Multichem A1cJJX · Abbreviated | Technopath Manufacturing | 10/26/2016SE |
| K161874 | Audit MicroControls Linearity DROP LQ Blood GlucoseJJX · Traditional | Aalto Scientific, Ltd. | 08/10/2016SE |
| K161526 | LIAISON CMV IgM Serum Control SetJJX · Special | DiaSorin, Inc. | 06/30/2016SE |
| K161522 | LIAISON EBV IgM Serum Control SetJJX · Special | DiaSorin, Inc. | 06/30/2016SE |
| K161082 | IDS-iSYS 17-OH Progesterone Control Set, IDS-iSYS 17-OH Progesterone Calibration VerifiersJJX · Traditional | Immunodiagnostic Systems , Ltd. | 05/17/2016SE |
| K152117 | Dropper hsCRP High Sensitivity CRP ControlJJX · Traditional | Quantimetrix Corporation | 04/21/2016SE |
| K151742 | Contour Next Control SolutionJJX · Traditional | Bayer Healthcare | 09/23/2015SE |
| K143687 | ADVIA Centaur Follicle Stimulating Hormone (FSH) Master Curve Material, ADVIA Centaur…JJX · Traditional | Siemens Healthcare Diagnostics, Inc. | 07/17/2015SE |
More from Siemens Healthcare Diagnostics, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K163629 | Audit MicroControls Linearity FD Tumor Markers IIJJY · Traditional | 03/10/2017SE |
| K161874 | Audit MicroControls Linearity DROP LQ Blood GlucoseJJX · Traditional | 08/10/2016SE |
| K143573 | Audit MicroControls Linearity FD Tumor Markers IIJJY · Traditional | 01/16/2015SE |
| K143026 | Audit MicroControls Linearity FD Unsaturated Iron Binding CapacityJJX · Traditional | 11/21/2014SE |
| K142978 | Audit MicroControls Linearity LQ Special DiabetesJJY · Traditional | 11/20/2014SE |
| K130762 | Audit Microcv Therapeutic Drug (TDM) Linearity SetJJY · Traditional | 04/29/2013SE |
| K130764 | Audit Microcv Vitamin D Linearity SetJJX · Traditional | 04/26/2013SE |
| K130157 | Audit Microcv Beta-Hydroxybutyric Acid Linearity SetJJX · Traditional | 03/19/2013SE |
| K112742 | Audit Microlq Spinal Fluid ControlJJY · Traditional | 06/15/2012SE |
| K111964 | Audit Microcv Urine/Fluids Chemistry LinearityJJY · Traditional | 03/02/2012SE |
Questions and answers
When was Audit MicroControls Linearity LQ Cystatin-C cleared by the FDA?
Audit MicroControls Linearity LQ Cystatin-C (K143571) received a 510(k) decision of Substantially Equivalent on January 23, 2015, 37 days after the submission was received.
What is the product code of K143571?
The FDA product code is JJX – Single (Specified) Analyte Controls (Assayed And Unassayed), a Class I (low risk) device regulated under 21 CFR 862.1660.